Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase I Study of CD19 Specific T Cells in CD19 Positive Malignancy (CD19)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2013 by The Christie NHS Foundation Trust.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Professor Robert Hawkins, Christie Hospital NHS Foundation Trust Identifier:
First received: December 14, 2011
Last updated: November 25, 2013
Last verified: November 2013
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)